Spiro Rombotis is the founder of Cyclacel Pharmaceuticals. Cyclacel Pharmaceuticals has raised $93M in total funding. Based in Berkeley Heights, NJ.
Spiro Rombotis served as the President and CEO of Cyclacel Pharmaceuticals. The company is focused on developing a pipeline of anti-cancer drug candidates and advancing preclinical drug pipelines derived from cell cycle biology research. In 2006, Cyclacel raised $45 million through a private stock placement, and in 2001, it secured $47.7 million for its cell-cycle cancer programs.
Full founder directory · Investor directory · Company funding database · Fundraising library